M

Researcher Profile

Michael Heinsch

1

Publications

143

Citations

10

Co-Authors

1

Active Years

Publications

Journal Article The Lancet Haematology Nov 01, 2022

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

Hartmut Goldschmidt · Elias K Mai · Uta Bertsch · Roland Fenk +88 more

10.1016/s2352-3026(22)00263-0 143 citations

Publication Timeline

2022

1

Frequent Co-Authors

Andreas Schwarzer

Stefan Fronhoffs

Anne M Asemissen

Stephan Kremers